Pre-eclampsia: risk, warning signs, and specialist care
Pre-eclampsia is a pregnancy disorder involving new hypertension and maternal organ or placental dysfunction; early recognition changes monitoring and timing decisions.
High-risk pregnancy / Your pregnancy companion
You are more than
a risk factor.
A diagnosis can change the plan. It should not take away your understanding of it. Find thoughtful answers, useful evidence, and a little more room to breathe.
Find what matters to youA gentler starting point
“High risk” means closer care. It does not tell you how your story ends.
Explore the knowledge library
Understand your situation.
Gestational diabetes: monitoring mother and baby
Gestational diabetes care combines glucose targets, nutrition, medication when needed, fetal growth assessment, and a delivery and postpartum plan.
Preterm birth risk: cervix, history, symptoms, and prevention
Preterm-birth assessment separates recurrence risk, cervical shortening, and true preterm labour so surveillance and prevention match the clinical problem.
Placenta previa and placenta accreta spectrum
Placenta location, previous uterine surgery, ultrasound signs, bleeding, and delivery resources determine the care pathway for previa and accreta risk.
Pregnancy after stillbirth, recurrent loss, or severe complications
A new pregnancy after loss needs an explanation-focused review, recurrence-risk plan, targeted prevention, and care that acknowledges psychological safety.
Twins and multiple pregnancy: why chorionicity changes risk
Twin care depends first on chorionicity and amnionicity, then on growth, fluid, Doppler, cervix, maternal health, and signs of shared-placenta complications.
Prevention, with perspective
Can a plan change
the odds?
Sometimes, yes. But the useful answer includes who was studied, what changed, and what the finding means for you. Here is one important example.
Preterm pre-eclampsia
Affected pregnancies, % · Screen-selected high-risk singleton pregnancies · 1,620 with follow-up
Aspirin group13 / 798 pregnancies
1.6%
Placebo group35 / 822 pregnancies
4.3%
Outcome: pre-eclampsia leading to delivery before 37 weeks. Trial percentages are not your personal risk or Mediclinic outcomes.
About 3 feweraffected pregnancies per 100 in this trial
The trial compared clinician-prescribed aspirin with placebo in a specific high-risk group. The difference was statistically significant.
Adjusted odds ratio (95% confidence interval): 0.38 (0.20–0.74)
A conversation, not a prescription
Understand pre-eclampsia in depth Do not start, stop, or change aspirin from this chart. Your clinician should assess your history, bleeding risks, allergies, dose, and timing. Prevention does not replace monitoring.
Study details and source
ASPRE randomized 1,776 participants. The primary outcome analysis included 798 in the aspirin group and 822 in the placebo group after withdrawals and loss to follow-up. Trial regimen: 150 mg daily from 11–14 until 36 weeks. This describes the research, not a universal treatment schedule.
Rolnik et al. · NEJM 2017 · DOI: 10.1056/NEJMoa1704559Understand your baseline
Previous pregnancies, health conditions, medicines, and the current findings shape the plan.
Agree what to follow
Know which symptoms, measurements, blood tests, and scans matter in your situation.
Know when to call
Severe symptoms need urgent assessment. An online request is not an emergency service.
Make the most of your appointment
Bring your questions. Leave with a plan.
Use this checklist as a conversation starter. Tick the questions you want to ask, then print this page to take with you.
Selections stay on this page only and are not sent or saved.
Care in the UAE
Where assessment and treatment take place
Specialist MFM assessment is available through Mediclinic Airport Road Hospital in Abu Dhabi and Mediclinic Al Jowhara Hospital in Al Ain. Fetal-therapy procedures are coordinated through the designated Abu Dhabi programme. Patients in Dubai can enter the diagnostic and referral pathway through Mediclinic, with the appropriate location confirmed during triage.
Abu Dhabi
Mediclinic Airport Road Hospital
Specialist assessment and the fetal-therapy procedure hub.
View location ↗
Al Ain
Mediclinic Al Jowhara Hospital
Full maternal–fetal diagnostics and coordinated referral.
View location ↗Dubai
Mediclinic referral pathway
Diagnostic and referral access through Mediclinic. The team confirms the appropriate facility during triage.
Ask the referral team ↗Questions, answered
A few things you may be wondering.
Does a specialist referral mean something is wrong?
Not necessarily. An assessment may offer reassurance, clarify an uncertain finding, or plan closer care. The reason for referral determines the next step.
Can I contact the team myself?
Yes. The self-referral form needs your name, phone number, city, and a brief explanation. Other details are optional. The team will contact you and arrange any records needed.
Where do assessment and treatment take place?
Specialist MFM assessment is available through Mediclinic Airport Road Hospital in Abu Dhabi and Mediclinic Al Jowhara Hospital in Al Ain. Fetal-therapy procedures are coordinated through the designated Abu Dhabi programme. Patients in Dubai can enter the diagnostic and referral pathway through Mediclinic, with the appropriate location confirmed during triage.
How do I prepare for a second opinion?
Write down the question you want answered and your gestational age. Have your reports and previous results available. The team will explain how to share any images securely after making contact.
When should I seek urgent help?
Heavy bleeding, severe pain, fluid loss, reduced fetal movements, collapse, breathing difficulty, seizures, or a severe headache with visual symptoms need immediate medical assessment. Do not wait for an online form response.
Your next step
Let’s make the next step clearer.
Tell the team your concern. We will contact you to help coordinate the right assessment.